Ultrasonographic Assessment for Tenosynovitis in Juvenile Idiopathic Arthritis with Ankle Involvement: Diagnostic and Therapeutic Significance.
ankle
biological therapy
juvenile idiopathic arthritis
methotrexate
ultrasonography
Journal
Children (Basel, Switzerland)
ISSN: 2227-9067
Titre abrégé: Children (Basel)
Pays: Switzerland
ID NLM: 101648936
Informations de publication
Date de publication:
03 Apr 2022
03 Apr 2022
Historique:
received:
03
03
2022
revised:
29
03
2022
accepted:
01
04
2022
entrez:
23
4
2022
pubmed:
24
4
2022
medline:
24
4
2022
Statut:
epublish
Résumé
The role of musculoskeletal ultrasound in JIA is still controversial, although there is growing evidence on its utility, especially in the diagnosis of tenosynovitis. We presented a retrospective cross-sectional study of a group of patients with JIA with ankle swelling followed in a Pediatric Rheumatology Service of a tertiary-level pediatric hospital in Northern Italy during the follow-up period between January 1st 2003 and December 31st 2019. Preliminary results have been presented at the EULAR Congress 2021. We enrolled only patients who underwent msk-US, and we identified those with a clinical and sonographic diagnosis of tenosynovitis. For each patient, we collected data on demographics, clinical characteristics, and therapeutic strategies during the follow-up. On December 31st 2019, 56 swollen ankles of 48 patients were assessed with msk-US. Twenty-two ankles showed sonographic signs of joint synovitis, sixteen ankles presented signs of both joint synovitis and tenosynovitis, and fourteen ankles presented sonographic signs of tenosynovitis only. Overall, tenosynovitis was detected on 27 (56%) out of 48 children with at least a swollen ankle. In 13 patients out of 27 with tenosynovitis (48%), there was no joint synovitis of ankle or foot. Twenty-five patients with tenosynovitis (92%) achieved clinical and radiological remission: seven patients achieved remission of tenosynovitis with methotrexate only, and fifteen patients with biological drugs alone or in combination therapy. We observed that more than half of the patients with ankle swelling presented a tenosynovitis, and about 50% of them did not show sonographic signs of an active joint synovitis. Among patients with tenosynovitis, biological therapy alone or in association with DMARDs showed effectiveness in inducing disease remission.
Sections du résumé
BACKGROUND
BACKGROUND
The role of musculoskeletal ultrasound in JIA is still controversial, although there is growing evidence on its utility, especially in the diagnosis of tenosynovitis.
METHODS
METHODS
We presented a retrospective cross-sectional study of a group of patients with JIA with ankle swelling followed in a Pediatric Rheumatology Service of a tertiary-level pediatric hospital in Northern Italy during the follow-up period between January 1st 2003 and December 31st 2019. Preliminary results have been presented at the EULAR Congress 2021. We enrolled only patients who underwent msk-US, and we identified those with a clinical and sonographic diagnosis of tenosynovitis. For each patient, we collected data on demographics, clinical characteristics, and therapeutic strategies during the follow-up.
RESULTS
RESULTS
On December 31st 2019, 56 swollen ankles of 48 patients were assessed with msk-US. Twenty-two ankles showed sonographic signs of joint synovitis, sixteen ankles presented signs of both joint synovitis and tenosynovitis, and fourteen ankles presented sonographic signs of tenosynovitis only. Overall, tenosynovitis was detected on 27 (56%) out of 48 children with at least a swollen ankle. In 13 patients out of 27 with tenosynovitis (48%), there was no joint synovitis of ankle or foot. Twenty-five patients with tenosynovitis (92%) achieved clinical and radiological remission: seven patients achieved remission of tenosynovitis with methotrexate only, and fifteen patients with biological drugs alone or in combination therapy.
CONCLUSIONS
CONCLUSIONS
We observed that more than half of the patients with ankle swelling presented a tenosynovitis, and about 50% of them did not show sonographic signs of an active joint synovitis. Among patients with tenosynovitis, biological therapy alone or in association with DMARDs showed effectiveness in inducing disease remission.
Identifiants
pubmed: 35455553
pii: children9040509
doi: 10.3390/children9040509
pmc: PMC9031705
pii:
doi:
Types de publication
Journal Article
Langues
eng
Références
Ann Rheum Dis. 2020 Apr;79(4):437-439
pubmed: 32060038
Clin Immunol. 2020 May;214:108396
pubmed: 32229291
Arthritis Care Res (Hoboken). 2021 Aug;73(8):1180-1186
pubmed: 32339404
J Rheumatol. 2010 Nov;37(11):2409-14
pubmed: 20843904
Ann Rheum Dis. 2001 Jul;60(7):641-9
pubmed: 11406516
Arthritis Rheumatol. 2021 Nov;73(11):1966-1975
pubmed: 34582120
Nat Rev Rheumatol. 2012 Mar 27;8(6):329-36
pubmed: 22450553
Rheumatology (Oxford). 2012 Jul;51(7):1299-303
pubmed: 22393028
Ann Rheum Dis. 2013 Aug;72(8):1328-34
pubmed: 22984169
Pediatr Rheumatol Online J. 2017 Apr 11;15(1):22
pubmed: 28399893
Arthritis Care Res (Hoboken). 2012 Mar;64(3):441-7
pubmed: 21972178
Ann Rheum Dis. 2016 Apr;76(4):666-672
pubmed: 27604532
Pediatr Rheumatol Online J. 2016 May 27;14(1):33
pubmed: 27234966
J Rheumatol. 2005 Dec;32(12):2485-7
pubmed: 16331793
Pediatr Rheumatol Online J. 2011 Jan 29;9(1):4
pubmed: 21276257
Arthritis Care Res (Hoboken). 2016 Sep;68(9):1346-53
pubmed: 26815641